Department of Pathological Anatomy

Medicine & Life Sciences

1. Indonesia 100%
2. Breast Neoplasms 45%
3. Neoplasms 43%
4. Uterine Cervical Neoplasms 27%
5. Colorectal Neoplasms 24%
6. Neoplasm Metastasis 21%
7. Immunohistochemistry 20%
8. Carcinoma 19%
9. Dextran Sulfate 18%
10. Staining and Labeling 17%
11. Squamous Cell Carcinoma 16%
12. Colon 16%
13. Lymphoma 15%
14. Drug Therapy 15%
15. Skin Neoplasms 14%
16. Bone and Bones 14%
17. Cell Line 14%
18. Apoptosis 14%
19. Caspase 3 14%
20. Lymph Nodes 13%
21. Biopsy 13%
22. Proteins 13%
23. Lymphoma, Large B-Cell, Diffuse 12%
24. T-Cell Lymphoma 12%
25. Japan 12%
26. Pleural Empyema 12%
27. Human Herpesvirus 4 11%
28. Control Groups 11%
29. Liver 11%
30. Adenocarcinoma 11%
31. Ethanol 10%
32. Therapeutics 10%
33. Survival 10%
34. Paraffin 10%
35. Inflammation 10%
36. Catenins 10%
37. Carcinogenesis 9%
38. Mutation 9%
39. Cell Biology 9%
40. Pathology 9%
41. Hepatocellular Carcinoma 9%
42. Mesenchymal Stem Cells 8%
43. Sprague Dawley Rats 8%
44. Osteosarcoma 8%
45. B-Lymphocytes 8%
46. Melanoma 8%
47. Genes 8%
48. Giant Cell Tumor of Bone 8%
49. Sarcoma 8%
50. Anti-Inflammatory Agents 8%
51. Keratin-19 8%
52. Ameloblastoma 7%
53. Population 7%
54. Cyclin D1 7%
55. Recurrence 7%
56. Fibrosis 7%
57. Ductal Carcinoma 7%
58. Case-Control Studies 7%
59. Cyclooxygenase 2 7%
60. Polyps 7%
61. General Hospitals 7%
62. Cell Proliferation 7%
63. Lymphocytes 7%
64. Annona 7%
65. antimycin 7%
66. Tuberculosis 7%
67. Wistar Rats 7%
68. Epidemiologic Studies 6%
69. Azoxymethane 6%
70. Giant Cell Tumors 6%
71. Ovarian Epithelial Carcinoma 6%
72. Incidence 6%
73. Skin 6%
74. Fruit 6%
75. NF-kappa B 6%
76. Cross-Sectional Studies 6%
77. Eosine Yellowish-(YS) 6%
78. Breast 6%
79. Wounds and Injuries 6%
80. Chronic Hepatitis B 6%
81. Basal Cell Carcinoma 6%
82. Curcumin 6%
83. Nasopharyngeal Carcinoma 6%
84. T-Lymphocytes 6%
85. Endometrioid Carcinoma 6%
86. In Vitro Techniques 6%
87. Sensitivity and Specificity 6%
88. Chitosan 6%
89. Natural Killer Cells 6%
90. Growth 6%
91. Embryonal Rhabdomyosarcoma 6%
92. Pomegranate 6%
93. Neoplastic Stem Cells 6%
94. Messenger RNA 6%
95. Wound Healing 6%
96. Biomarkers 6%
97. nucleolar organizer region associated proteins 6%
98. Hematoxylin 6%
99. Endometriosis 6%
100. Cancer-Associated Fibroblasts 6%